Literature DB >> 21755497

Binding and transport of PAMAM-RGD in a tumor spheroid model: the effect of RGD targeting ligand density.

Carolyn L Waite1, Charles M Roth.   

Abstract

The mechanisms governing the efficient tumor spheroid penetration and transport by poly(amidoamine) (PAMAM) dendrimers displaying varying numbers of cyclic RGD targeting peptides (2, 3, 7, or 10) were evaluated in this work. The cell-free binding affinities and cellular internalization kinetics of PAMAM-RGD conjugates to malignant glioma cells were determined experimentally, and the results were incorporated into a mathematical model to predict the transport of these materials through a multicellular tumor spheroid. The theoretical analysis demonstrated that greater RGD crosslinking may improve transport through tumor spheroids due to their decreased integrin-binding affinity. This study provides evidence that altering the density of tumor-targeting ligands from a drug delivery platform is a feasible way to optimize the tumor-penetration efficiency of an anticancer agent, and provides insight into the physicochemical mechanisms governing the relative effectiveness of these conjugates.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21755497      PMCID: PMC3193538          DOI: 10.1002/bit.23255

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  27 in total

1.  Theoretical analysis of antibody targeting of tumor spheroids: importance of dosage for penetration, and affinity for retention.

Authors:  Christilyn P Graff; K Dane Wittrup
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

2.  Tumor angiogenic vasculature targeting with PAMAM dendrimer-RGD conjugates.

Authors:  Rameshwer Shukla; Thommey P Thomas; Jennifer Peters; Alina Kotlyar; Andrzej Myc; James R Baker
Journal:  Chem Commun (Camb)       Date:  2005-10-10       Impact factor: 6.222

3.  Multivalent RGD synthetic peptides as potent alphaVbeta3 integrin ligands.

Authors:  Elisabeth Garanger; Didier Boturyn; Jean-Luc Coll; Marie-Christine Favrot; Pascal Dumy
Journal:  Org Biomol Chem       Date:  2006-04-03       Impact factor: 3.876

4.  Quantification of the expression level of integrin receptor alpha(v)beta3 in cell lines and MR imaging with antibody-coated iron oxide particles.

Authors:  Sabrina Benedetto; Roberta Pulito; Simonetta Geninatti Crich; Guido Tarone; Silvio Aime; Lorenzo Silengo; Jörg Hamm
Journal:  Magn Reson Med       Date:  2006-10       Impact factor: 4.668

5.  Multivalent effects of RGD peptides obtained by nanoparticle display.

Authors:  Xavier Montet; Martin Funovics; Karin Montet-Abou; Ralph Weissleder; Lee Josephson
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

6.  Optimising non-viral gene delivery in a tumour spheroid model.

Authors:  H R Mellor; L A Davies; H Caspar; C R Pringle; S C Hyde; D R Gill; R Callaghan
Journal:  J Gene Med       Date:  2006-09       Impact factor: 4.565

7.  Engineering lipid vesicles of enhanced intratumoral transport capabilities: correlating liposome characteristics with penetration into human prostate tumor spheroids.

Authors:  Kostas Kostarelos; Dimitris Emfietzoglou; Alexandros Papakostas; Wei-Hong Yang; Ase M Ballangrud; George Sgouros
Journal:  J Liposome Res       Date:  2005       Impact factor: 3.648

Review 8.  Drug penetration in solid tumours.

Authors:  Andrew I Minchinton; Ian F Tannock
Journal:  Nat Rev Cancer       Date:  2006-08       Impact factor: 60.716

9.  Targeting cancer micrometastases with monoclonal antibodies: a binding-site barrier.

Authors:  T Saga; R D Neumann; T Heya; J Sato; S Kinuya; N Le; C H Paik; J N Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-12       Impact factor: 11.205

10.  Co-regulation of cell adhesion by nanoscale RGD organization and mechanical stimulus.

Authors:  Lily Y Koo; Darrell J Irvine; Anne M Mayes; Douglas A Lauffenburger; Linda G Griffith
Journal:  J Cell Sci       Date:  2002-04-01       Impact factor: 5.285

View more
  15 in total

1.  Peptide- and saccharide-conjugated dendrimers for targeted drug delivery: a concise review.

Authors:  Jie Liu; Warren D Gray; Michael E Davis; Ying Luo
Journal:  Interface Focus       Date:  2012-03-21       Impact factor: 3.906

Review 2.  Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities.

Authors:  Carolyn L Waite; Charles M Roth
Journal:  Crit Rev Biomed Eng       Date:  2012

3.  Investigating the optimal size of anticancer nanomedicine.

Authors:  Li Tang; Xujuan Yang; Qian Yin; Kaimin Cai; Hua Wang; Isthier Chaudhury; Catherine Yao; Qin Zhou; Mincheol Kwon; James A Hartman; Iwona T Dobrucki; Lawrence W Dobrucki; Luke B Borst; Stéphane Lezmi; William G Helferich; Andrew L Ferguson; Timothy M Fan; Jianjun Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

4.  Evaluation of uptake and distribution of gold nanoparticles in solid tumors.

Authors:  Christopher G England; André M Gobin; Hermann B Frieboes
Journal:  Eur Phys J Plus       Date:  2015-11-19       Impact factor: 3.911

5.  RGD-conjugated solid lipid nanoparticles inhibit adhesion and invasion of αvβ3 integrin-overexpressing breast cancer cells.

Authors:  Dan Shan; Jason Li; Ping Cai; Preethy Prasad; Franky Liu; Andrew Michael Rauth; Xiao Yu Wu
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

6.  Use of protein-engineered fabrics to identify design rules for integrin ligand clustering in biomaterials.

Authors:  Patrick L Benitez; Shamik Mascharak; Amy C Proctor; Sarah C Heilshorn
Journal:  Integr Biol (Camb)       Date:  2015-12-21       Impact factor: 2.192

7.  Multifunctional nanorods serving as nanobridges to modulate T cell-mediated immunity.

Authors:  Young Ju Son; Hyesung Kim; Kam W Leong; Hyuk Sang Yoo
Journal:  ACS Nano       Date:  2013-10-09       Impact factor: 15.881

8.  PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors.

Authors:  Marxa Figueiredo; Rinat Esenaliev
Journal:  J Drug Deliv       Date:  2012-02-28

9.  Endothelial cell-targeted pVEGF165 polyplex plays a pivotal role in inhibiting intimal thickening after vascular injury.

Authors:  Shouqin Tian; Duanwen Cao; Haijuan Zou; Feng Bai; Zhongjuan Wang; Shirong Pan; Min Feng
Journal:  Int J Nanomedicine       Date:  2015-09-10

Review 10.  Dendrimers as carriers for siRNA delivery and gene silencing: a review.

Authors:  Jiangyu Wu; Weizhe Huang; Ziying He
Journal:  ScientificWorldJournal       Date:  2013-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.